Form 4 for CNTX Context Therapeutics Inc.
Accepted 2022-08-22 00:00:00 ET · period of report 2022-08-19 · accession 0001842952-22-000081 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-22 | 2022-08-19 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $1.85 | +13.0K | 102.6K | +15% | +$24.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-19 | P | A | 13,000 | $1.85 | 102,583 | D | — | — |